Next 10 |
Owens Corning Inc New (OC) is expected to report $2.82 for Q4 2023 Getty Realty Corporation (GTY) is expected to report $0.56 for Q4 2023 Bion Environmental Technologies Inc. (BNET) is expected to report for Q2 2024 Nexien BioPharma Inc (NXEN) is expected to report for Q2 2024 Ayt...
The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Nabriva Therapeutics plc (NBRVF) is expected to report for Q2 2023 JFE Holdings, Inc. (JFEEF) is expected to report for Q1 2024 Superior Gold Inc (SUPGF) is expected to report for Q2 2023 S&W Seed Company (SANW) is expected to report $-0.09 for Q4 2023 Jefferies Financial Grou...
Westbury Bancorp Inc (WBBW) is expected to report for quarter end 2023-06-30 Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected to report for Q1 2024 Belgravia Hartford Capital Inc (BLGVF) is expected to report for Q2 2023 Yasheng Group (HERB) is expected to report for Q2 2023 ...
Software AG ADR (STWRY) is expected to report for Q2 2023 Dai Nippon Printing Co Ltd ADR (DNPLY) is expected to report for quarter end 2023-06-30 Coffee Holding Co. Inc. (JVA) is expected to report for Q1 2024 Calloway`s Nursery, Inc. (CLWY) is expected to report for Q2 2023 Home ...
Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $0.02 for Q2 2024 Screen Holdings Co. Ltd. (DINRF) is expected to report for Q1 2024 Bionik Laboratories Corp (BNKL) is expected to report for Q1 2024 Atento S.A. (ATTOF) is expected to report for Q2 2023 Akoustis Te...
Nexien BioPharma Inc (NXEN) is expected to report for Q3 2023
DENVER, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Nexien BioPharma, Inc. ("Nexien"or the"Company") (OTCQB:NXEN), a next generation biopharmaceutical company focused on research, development and commercialization of novel FDA-compliant cannabinoid pharmaceuticals and related drug delivery systems, t...
The patent relates to the administration of a specific composition comprised of cannabinoids to a patient Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development and comme...
News, Short Squeeze, Breakout and More Instantly...
Owens Corning Inc New (OC) is expected to report $2.82 for Q4 2023 Getty Realty Corporation (GTY) is expected to report $0.56 for Q4 2023 Bion Environmental Technologies Inc. (BNET) is expected to report for Q2 2024 Nexien BioPharma Inc (NXEN) is expected to report for Q2 2024 Ayt...
The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...